Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity (Q79849693)
Jump to navigation
Jump to search
scientific article published on 01 March 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity |
scientific article published on 01 March 2007 |
Statements
Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity (English)
L Zahiragic
C Schliemann
R Bieker
N H Thoennissen
K Burow
C Kramer
M Zühlsdorf
W E Berdel
1 March 2007